首頁 > 市場調查報告書 > 醫療設備

手術用器具泌尿科

市場調查報告書

商品編碼

1374803

全球碎石設備市場 -2023-2030

Global Lithotripsy Devices Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

碎石設備是泌尿科和腎臟科用於進行碎石術的醫療設備或機器，碎石術是一種非侵入性醫療程序，旨在分解和破碎泌尿道不同區域（例如腎臟、輸尿管或腎臟）中形成的結石或結石。膀胱。

碎石設備是研究和培訓環境中的重要設備，用於檢查碎石技術並對醫療保健專業人員進行使用教育，強調其在改善患者護理和醫療實踐方面的多功能性。

近年來，由於技術進步以及尿路結石和其他泌尿道疾病病例的增加，碎石設備市場顯著成長。

市場動態：促進因素與限制因素

碎石設備的不斷進步

由於持續的技術改進，預計碎石設備市場將推動市場發展。這些發展正在改變泌尿外科和腎臟病學領域，提高碎石手術的有效性和安全性，並推動市場成長。

例如，2022 年 2 月，Applaud Medical 的聲學增強器技術獲得了 FDA 的突破性裝置頭銜。這項創新旨在與輸尿管鏡雷射碎石術 (URS-LL) 結合使用，以分解尺寸從 6 毫米到 20 毫米的鈣基腎結石。聲學增強器是一個充滿氣體的小氣泡，並被專門為此目的設計的脂質殼覆蓋。

此外，2021年2月，美國食品藥物管理局（FDA）批准了衝擊波血管內碎石（IVL）系統用於治療高度鈣化的冠狀動脈斑塊。該裝置使用球囊提供能夠穿過軟動脈組織的聲壓波，主要目的是選擇性地分解鈣化斑塊以改善支架插入。

此外，尿路結石和泌尿道疾病的盛行率不斷增加以及人口老化是預計在預測期內推動全球碎石設備市場的其他主要因素。

市場動態：克制

碎石設備的高成本是該市場的主要限制，特別是在醫療保險機會有限的發展中國家。例如，根據澳洲健康與福利研究所 2023 年的文章，膽管結石碎石術的平均費用可能在 2,100-3,300 美元之間。

此外，與碎石手術相關的副作用和併發症導致疼痛、瘀傷和腎損傷的風險，以及取石替代療法的可用性是在預測期內抑制市場的因素。

For instance, in February 2022, Applaud Medical obtained a Breakthrough Device Designation from the FDA for its Acoustic Enhancer technology. This innovation is intended to be used in combination with ureteroscopy with laser lithotripsy (URS-LL) to break down calcium-based kidney stones ranging in size from 6 mm to 20 mm. The Acoustic Enhancer is a small bubble filled with gas and covered by a lipid shell that has been specially designed for this purpose.

Furthermore, in February 2021, The US Food and Drug Administration (FDA) has approved the Shockwave intravascular lithotripsy (IVL) system for the treatment of highly calcified coronary arterial plaques. This device uses a balloon to provide sonic pressure waves capable of passing through soft artery tissue, with the main objective of selectively breaking down calcified plaque to improve stent insertion.

Furthermore, the increasing prevalence of urolithiasis and urinary tract disorders and aging population are some of the other major factors that are expected to drive the global lithotripsy devices market over the forecast period.

Market Dynamics: Restraint

The high cost associated with the lithotripsy devices is major restraint for this market, especially in developing countries with limited access to healthcare insurance. For instance, according to Australian Institute of Health and Welfare 2023 article, the average cost of lithotripsy of bile duct stones may range within $2,100-3,300.

Furthermore, the side effects and complications associated with the lithotripsy procedures causing pain, bruising, and the risk of renal injury and and the availability of alternative treatments for stone removal are the factors that will restrain the market over the forecast period.

Segment Analysis

The global lithotripsy devices is segmented based on type, application, end user and region.

The extracorporeal shock wave lithotripsy devices segment accounted for approximately 54.2 % of the market share

The extracorporeal shock wave lithotripsy devices segment accounted for 54.2% and it is expected to be dominated during the forecast period. Extracorporeal shock wave lithotripsy is a technique that uses a lithotripter to produce a series of shock waves to break up stones in the urinary system, bile ducts, or pancreatic ducts. The segment is expected to drive owing to the increasing centers for lithotripsy and rising prevalence of kidney stones where extracorporeal shock wave lithotripsy devices play a major role.

For instance, in May 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.

Furthermore, the rising prevalence of kidney stones is major driving factors for this segment. For instance, according to National Kidney Foundation article, approximately one in ten people is expected to have kidney stone at some stage of their life. Moreover, more than one million people go the emergency rooms for kidney stone every year. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Analysis

North America accounted for approximately 37.4% of the market share in 2022

North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of kidney disease, product approvals, rising geriatric population, collaboration with the key players, and others that will drive this region further during the forecast period.

For instance, Adventist Health Hanford invested about USD 250,000 in November 2022 to acquire the Lumenis Pulse 120H Holmium Laser System with MOSES Technology. This cutting-edge device not only allows for speedier surgeries, saving up to 20% of the time, but it also decreases anesthetic usage, promotes faster patient recovery, and allows for outpatient treatment without hospitalization.

Furthermore, according to the Centers for Disease Control and Prevention, around 37 million people, or one in every seven adults or 15% of the adult population, were expected to have chronic renal disease by July 2022. As the prevalence of kidney disease rises, more than 50,000 lithotripsy treatments are conducted in the U.S. each year, contributing to the growth of the lithotripsy device market over the forecast period.

COVID-19 Impact Analysis

The lithotripsy device market is expected to face a setback as a result of the COVID-19 outbreak. When the pandemic occurred, the growth of the lithotripsy device industry halted. Surgical operations and non-urgent medical treatments unrelated to COVID-19 were placed on hold or canceled for the time being.

For instance, Kidney Care UK provided data in March 2021 indicating that the National Health Service (NHS) disrupted the care of more than 56% of patients. Furthermore, the report indicated that more than 28% of patients were waiting for procedures and were unable to acquire basic appointments. Furthermore, more than 18% of patients experienced difficulty reaching their general practitioners or hospital teams for medical consultations, and more than 7% reported worsening health as a result of delayed care. However, the market is expected to be stable and grow over the period of time as the resumption of all services occurs.

Competitive Landscape

The major global players in the lithotripsy devices market include: Olympus Corporation, Boston Scientific Corporation, NOVAMEDTEK, Inceler Medikal Co. Ltd., EDAP TMS, Advin Health Care, MTS Medical, STORZ MEDICAL AG, Shenzhen Huikang Medical Apparatus Co., Ltd., Medispec and among others.

Key Developments

In May 2, 2023, the Government Kilpauk Medical College (KMC) Hospital launched an extracorporeal shock wave lithotripsy (ESWL) Treatment Center. MOBIS India Foundation financed the ESWL machine, which costs 2.3 crore, as part of its corporate social responsibility funding.
In March 31, 2022, Shockwave Medical, Inc., a pioneer in the advancement of Intravascular Lithotripsy (IVL) for treating severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5 + peripheral IVL catheter following CE Mark and FDA clearance. The Shockwave M5 + catheter, which has only recently been available, is specifically developed to reduce IVL treatment time, provide alternate access options, and expand IVL therapy to patients with larger vessel diameters.

Why Purchase the Report?

To visualize the global lithotripsy devices market segmentation-based on type, application, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of lithotripsy devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global lithotripsy market report would provide approximately 77 tables, 77 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. The continuous advancements in lithotripsy devices
- 4.1.2. Restraints
  - 4.1.2.1. The high cost associated with the lithotripsy devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Extracorporeal Shock Wave Lithotripsy Devices*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Intracorporeal Lithotripsy Devices

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Kidney Stones*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ureteral Stones
8.4. Pancreatic Stones
8.5. Bile Duct Stones

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Olympus Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Boston Scientific Corporation
12.3. NOVAMEDTEK
12.4. Inceler Medikal Co. Ltd.
12.5. EDAP TMS
12.6. Advin Health Care
12.7. MTS Medical
12.8. STORZ MEDICAL AG
12.9. Shenzhen Huikang Medical Apparatus Co., Ltd.
12.10. Medispec

LIST NOT EXHAUSTIVE